Refine
Has Fulltext
- yes (23)
Is part of the Bibliography
- yes (23)
Year of publication
- 2024 (23) (remove)
Document Type
- Journal article (23) (remove)
Language
- English (23) (remove)
Keywords
- cell biology (2)
- ATF4 (1)
- C.376A>G (p.S126G) (1)
- Covid-19 (1)
- DCM genetic background (1)
- DNA double-strand breaks (1)
- DNA-encoded library synthesis (1)
- DNA-tagged amines (1)
- Drosophila (1)
- Fabry disease (1)
Institute
- Neurologische Klinik und Poliklinik (5)
- Institut für Organische Chemie (3)
- Theodor-Boveri-Institut für Biowissenschaften (3)
- Comprehensive Cancer Center Mainfranken (2)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (2)
- Institut für Klinische Biochemie und Pathobiochemie (2)
- Institut für Pharmakologie und Toxikologie (2)
- Institut für Pharmazie und Lebensmittelchemie (2)
- Institut für Psychologie (2)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (2)
Sonstige beteiligte Institutionen
RBM20 mutations account for 3 % of genetic cardiomypathies and manifest with high penetrance and arrhythmogenic effects. Numerous mutations in the conserved RS domain have been described as causing dilated cardiomyopathy (DCM), whereas a particular mutation (p.R634L) drives development of a different cardiac phenotype: left-ventricular non-compaction cardiomyopathy. We generated a mutation-induced pluripotent stem cell (iPSC) line in which the RBM20-LVNC mutation p.R634L was introduced into a DCM patient line with rescued RBM20-p.R634W mutation. These DCM-634L-iPSC can be differentiated into functional cardiomyocytes to test whether this RBM20 mutation induces development of the LVNC phenotype within the genetic context of a DCM patient.